IL-12 at the crossroads.
Hall
S S
SS
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000276:Adjuvants, Immunologic; D000818:Animals; D006801:Humans; D007111:Immunity, Cellular; D007239:Infections / Q000276:immunology* / Q000628:therapy; D018664:Interleukin-12 / Q000276:immunology / Q000627:therapeutic use* / Q000633:toxicity; D007896:Leishmaniasis / Q000628:therapy; D008288:Malaria / Q000628:therapy; D012552:Schistosomiasis / Q000628:therapy; D018417:Th1 Cells / Q000276:immunology*; D014376:Tuberculosis / Q000628:therapy; D014612:Vaccines / Q000276:immunology*
D000276:Adjuvants, Immunologic; D014612:Vaccines; D018664:Interleukin-12